Restart Life Sciences Corp. (CSE:HEAL)
Canada
· Delayed Price · Currency is CAD 0.110
+0.015 (15.79%)
Feb 21, 2025, 4:00 PM EST
Restart Life Sciences Revenue
Restart Life Sciences had revenue of -28.35K CAD in the twelve months ending September 30, 2024, down -200.00% year-over-year.
Revenue (ttm)
-28.35K
Revenue Growth
-200.00%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Royal Bank of Canada | 54.11B |
| The Toronto-Dominion Bank | 53.24B |
| Enbridge | 53.47B |
| Brookfield | 127.68B |
| Thomson Reuters | 10.44B |
| Bank of Montreal | 29.03B |
| Constellation Software | 13.09B |
| Canadian Pacific Kansas City | 14.55B |